10-12 September 2018 //  Lancaster Royal Hotel, London


  • Letter
    • C
  • Marc Cartellieri

    Marc Cartellieri

    Chief Scientific Officer, Cellex Patient Treatment GmbH
  • Benoit Champluvier

    Dr Benoit Champluvier

    Chief Technology and Manufacturing Officer, Bone Therapeutics
  • David D. Chang

    Dr David D. Chang

    Executive Vice President R & D and Chief Medical Officer, Kite Pharma, Inc
  • Andrea Chiesi

    Dr Andrea Chiesi

    Director, R&D, Portfolio Management; Co-Founder & Chief Executive Officer, Chiesi Farmaceutici SpA; Holostem
  • Michael Covington

    Mr Michael Covington

    Principal CMC Regulatory Policy and Strategy, Juno Therapeutics, Inc
  • Nick Crabb

    Dr Nick Crabb

    Programme Director, Scientific Affairs, Centre for Health Technology Evaluation, National Institute for Health & Care Excellence
6 Results

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad